Clinical applications of targeted temperature management

Area of Science:

• Neurology
• Critical Care Medicine
• Cardiovascular Medicine

Background:

• Targeted temperature management (TTM), historically known as therapeutic hypothermia, has a century-long history.
• Its initial application aimed to reduce metabolic rate for brain healing.
• Modern TTM focuses on neuroprotection against focal or global neurologic injury.

Observation:

• TTM's efficacy is supported by basic science, targeting cellular mechanisms like oxidative stress and apoptosis.
• Landmark studies from ten years ago confirmed TTM benefits for comatose cardiac arrest survivors.
• Positive outcomes are also noted in neonates with hypoxic-ischemic encephalopathy.

Findings:

• Human efficacy data for TTM varies across conditions, with limited evidence for some applications.
• Ongoing trials and conflicting results exist for TTM in ischemic stroke, traumatic brain injury, and myocardial infarction.
• TTM protocols are established for brain injury management, with known side effects.

Implications:

• Further research is crucial to clarify TTM's role in various neurological and critical care scenarios.
• In-depth examination of TTM for post-cardiac arrest care and pediatric applications is ongoing.
• Understanding TTM's benefits and limitations is key for optimizing patient outcomes in diverse clinical settings.